Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.202 SEK | -2.88% | -11.98% | -97.98% |
May. 16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 | |
May. 16 | Xbrane Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.98% | 29.73M | |
+31.28% | 50.85B | |
+1.24% | 42.82B | |
+48.77% | 42.03B | |
-4.22% | 29.55B | |
+10.98% | 26.11B | |
-22.31% | 19.13B | |
+7.56% | 13.05B | |
+26.80% | 12.16B | |
+23.00% | 12.08B |
- Stock Market
- Equities
- XBRANE Stock
- News Xbrane Biopharma AB
- Xbrane Biopharma AB Approves Election of Anders Tullgren as New Director of the Board and as Chairman of the Board